Thyroid hormones and cardiac arrhythmias

Vascular Pharmacology

Volumn 52, Issue 3-4, 2010, Pages 102-112

  Tribulova, Narcis ^a   Knezl, Vladimir ^b   Shainberg, Asher ^c   Seki, Shingo ^d   Soukup, Tomas ^e  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^c BAR ILAN UNIVERSITY   (Israel)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Arrhythmias; Ca2+ handling; Connexin 43; Ion channels; Thyroid hormone

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; CALCIUM ION; CONNEXIN 43; ION CHANNEL; LIOTHYRONINE; THYROID HORMONE; THYROID HORMONE DERIVATIVE; THYROXINE; UNCLASSIFIED DRUG;

ANTIARRHYTHMIC ACTIVITY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; DRUG MECHANISM; GENOME; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART PROARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTHYROIDISM; HYPOKALEMIA; HYPOTHYROIDISM; INCIDENCE; ION CURRENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SARCOLEMMA; SINUS RHYTHM;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CARDIAC ELECTROPHYSIOLOGY; HUMANS; ION CHANNELS; SARCOLEMMA; THYROID DISEASES; THYROID HORMONES; TIME FACTORS;

EID: 76849117681     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.10.001     Document Type: Review

References (177)

1. Almeida N.A., Cordeiro A., Machado D.S., Souza L.L., Ortiga-Carvalho T.M., Campos-de-Carvalho A.C., Wondisford F.E., and Pazos-Moura C.C. Connexin40 messenger ribonucleic acid is positively regulated by thyroid hormone (TH) acting in cardiac atria via the TH receptor. Endocrinology 150 (2009) 546-554
2. Arnold A.M., Danese M.D., Kuller L.H., Burke G.L., Tracy R.P., and Ladenson P.W. Thyroid status, cardiovascular risk, and mortality in older adults: the cardiovascular health study. Jama 295 (2006) 1033-1041
3. Aronow W.S. The heart and thyroid disease. Clin. Geriatr. Med. 11 (1995) 219-229
4. Ascheim D.D., and Hryniewicz K. Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid 12 (2002) 511-515
5. Auer J., Scheibner P., Mische T., Langsteger W., Eber O., and Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am. Heart J. 142 (2001) 838-842
6. Awais D., Shao Y., and Ismail-Beig F. Thyroid hormone regulation of myocardial Na/K-ATPase gene expression. J. Mol. Cell Cardiol. 32 (2000) 1969-1980
7. Bahouth S.W. Thyroid hormone regulation of transmembrane signalling in neonatal rat ventricular myocytes by selective alteration of the expression and coupling of G-protein alfa-subunits. Biochem. J. 307 (1995) 831-841
8. Barros F., Gomez V.D., Viloria C.G., Palomero T., Giraldez T., and Pena P. Modulation of human erg K+ channel gating by activation of a G-protein-coupled receptor and protein kinase C. J. Physiol. (Lond.) 511 (1998) 333-346
9. Beekman R.E., VanHardeveld C., and Somonides W.S. Effect of thyroid state on cytosolic free calcium in resting and electrically stimulated cardiac myocytes. Biochim. Biophys. Acta 969 (1988) 18-27
10. Biondi B., Fazio S., Coltori F., Palmieri E.A., Carella C., Lombardi G., and Sacca L. Clinical case seminar: reentrant atrioventricular nodal tachycardia induced by levothyroxine. J. Clin. Endocrinol. Metab. 83 (1998) 2643-2645
11. Biondi B., Palmieri E.A., Fazio S., Cosco C., Nocera M., Sacca L., Filetti S., Lombardi G., and Perticone F. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J. Clin. Endocrinol. Metab. 85 (2000) 4701-4705
12. Bokník P., Unkel C., Kirchhefer U., Kleideiter U., Klein-Wiele O., Knapp J., Linck B., Lüss H., Müller F.U., Schmitz W., Vahlensieck U., Zimmermann N., Jones L.R., and Neumann J. Regional expression of phospholamban in the human heart. Cardiovasc. Res. 42 (1999) 67-76
13. Bosch R.F., Wang Z., Li G.R., and Nattel S. Electrophysiological mechanisms by which hypothyroidism delays repolarization in guinea pig hearts. Am. J. Physiol. 277 (1999) H211-H220
14. Bowling N., Huang X., and Sandusky G.E. Protein kinase C-alpha and epsilon modulate connexin-43 phosphorylation in human heart. J. Mol. Cell Cardiol. 33 (2001) 789-798
15. Brik H., and Shainberg A. Thyroxine induces transition of red towards white muscle in cultured heart cells. Basic Res. Cardiol. 85 (1990) 237-246
16. Burashnikov A., and Antzelevitch C.H. Late-Phase EAD. A unique mechanism contributing to initiation of atrial fibrillation. PACE 29 (2006) 290-295
17. Burmeister L.A., and Flores A. Subclinical thyrotoxicosis and the heart. Thyroid 12 (2002) 495-499
18. Buscemi S., Verga S., Cottone S., Andronico G., D Orio L., Mannino V., Panzavecchia D., Vitale F., and Cerasola G. Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism. J. Endocrinol. Invest. 30 (2007) 230-235
19. Cappola A.R., Fried L.P., Carr A.N., and Kranias E.G. Thyroid hormone regulation of calcium cycling proteins. Thyroid 12 (2002) 453-457
20. Cappola A.R., Fried L.P., Arnold A.M., Danese M.D., Kuller L.H., Burke G.L., Tracy R.P., and Ladenson P.W. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295 (2006) 1033-1041
21. Cerillo A.G., Bevilacqua S., Storti S., Kallushi M.M.E., Ripoli A., Clerico A., and Glauber M. Free triiodothyronine: a novel predictor of postoperative atrial fibrillation. Cardio-Thorac. Surg. 24 (2003) 487-492
22. Cernohorsky J., Kolar F., Pelouch V., Korecky B., and Vetter R. Thyroid control sarcolemmal Na/Ca exchanger and SR Ca-ATPase in developing rat heart. Am. J. Physiol. 2751 (1998) H264-H273
23. Chen S.A., Hesieh M.H., Tai C.T., Tsai C.F., Prakash V.S., Yu W.C., Hsu T.L., Ding Y.A., and Chang M.S. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics pharmacological responses and effects of radiofrequency ablation. Circulation 100 (1999) 1879-1886
24. Chen Y.C., Chen S.A., Chen Y.J., Chang M.S., Chan P., and Lin C.I. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J. Am. Coll. Cardiol. 39 (2002) 366-372
25. Chess-Williams R., and Coker S.J. Ventricular fibrillation is reduced in hypothyroid rats with enhanced myocardial beta-adrenoceptor. Br. J. Pharmacol. 98 (1989) 95-100
26. Colkesen Y., Acil T., Demircan S., Sezgin A.T., Ozin B., and Muderrisoglu H. Echocardiographic features of patients with paroxysmal atrial fibrillation. Int. J. Cardiovasc. Imaging 24 (2008) 159-163
27. Colzani R.M., Emdin M., Conforti F., Passino C., Scarlattini M., and Iervasi G. Hyperthyroidism is associated with lengthening of ventricular repolarization. Clin. Endocrinol. (Oxf). 55 (2001) 27-32
28. Connely, T.J., El-Hayek, R., Sukhareva, M., Coronado, R., 1994. L-thyroxine activates the intracellular Ca2+ release channel of skeletal muscle sarcoplasmic reticulum. Biochem. Mol. Biol. Int. 32, 441-8.
29. Crozatier B., Su J.B., Corsin A., and Bouanani N.e.-H. Species differences in myocardial β-adrenergic receptor regulation in response to hyperthyroidism. Circ. Res. 69 (1991) 1234-1243
30. Danzi S., and Klein I. Thyroid hormone-regulated cardiac gene expression and cardiovascular disease. Thyroid 12 (2002) 467-472
31. Davis P.J., and Davis F.B. Nongenomic actions of thyroid hormone on the heart. Thyroid 12 (2002) 453-457
32. Davis P.J., and Davis F.B. Acute cellular actions of thyroid hormone and myocardial function. Ann. Thorac. Surg. 56 (1993) S16-S23
33. Davison E.T., and Davison M.J. Triiodothyronine (T3) toxicosis with hypokalemic periodic paralysis and ventricular tachycardia. J. Electrocardiol. 28 (1995) 161-164
34. Decker R.S. Hormonal regulation of gap junction differentiation. J. Cell Biol. 69 (1976) 669-685
35. Di Meo S., Venditti P., and De Leo T. Effect of iodothyronines on electrophysiological properties of rat papillary muscle fibres. Horm. Metab. Res. 29 (1997) 225-230
36. Dillmann W.H. Biochemical basis of thyroid hormone action in the heart. Am. J. Med. 88 (1990) 628-630
37. Dillman W.H. Cellular action of thyroid hormone on the heart. Thyroid 12 (2002) 447-466
38. Disatnik M.H., and Shainberg A. Regulation of beta-adrenoceptors by thyroid hormone and amiodarone in rat myocardiac cells in culture. Biochem. Pharmacol. 41 (1991) 1039-1044
39. Doble P.W., Ping P., and Kardami E. The ε subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ. Res. 86 (2000) 293-301
40. Dudley Jr. S.C., and Baumgarten C.M. Bursting of cardiac sodium channels after acute exposure to 3, 5, 3′-triiodo-l-thyronine. Circ. Res. 73 (1993) 301-313
41. Ehrlich J.R., Biliczki P., Hohnloser S.H., and Nattel S. Atrial-selective approaches for the treatment of atrial fibrillation. J. Am. Coll. Cardiol. 51 (2008) 787-791
42. El Shahawy M., Stefadouros M.A., Carr A.A., and Conti R. Direct effect of thyroid hormone on intracardiac conduction in acute and chronic hyperthyroid animals. Cardiovasc. Res. 9 (1975) 524-531
43. Factor M.A., Mayor G.H., Nachreiner R.F., and D'Alecy L.G. Thyroid hormone loss and replacement during resuscitation from cardiac arrest in dogs. Resuscitation 26 (1993) 141-162
44. Fadel B.M., Ellahham S., Ringel M.D., Lindsay Jr. J., Wartofsky L., and Burman K.D. Hyperthyroid heart disease. Clin. Cardiol. 23 (2000) 402-408
45. Fazio S., Palmieri E.A., Lombardi G., and Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent. Prog. Horm. Res. 59 (2004) 31-50
46. Feng Y., Dai D.Z., Na T., Cui B., Wang T., Zhang Y., and Dai Y. Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy. Pharmacol. Rep. 59 (2007) 306-314
47. Freudlund B.O., and Olsson S.B. Long QT interval and ventricular tachycardia of "Torsade de Pointe" type in hypothyroidism. Acta Med. Scand. 213 (1983) 231-235
48. Friberg L., Werner S., Eggertsen G., and Ahnve S. Rapid down-regulation of thyroid hormones in acute myocardial infarction. Is it cardioprotective in patients with angina?. Arch. Intern. Med. 162 (2002) 1388-1394
49. Gammage M.D., Parle J.V., Holder R.L., Roberts L.M., Hobbs F.D.R., Wilson S., Sheppard M.C., and Franklyn J.A. Association between serum free thyroxine concentration and atrial fibrillation. Arch. Intern. Med. 167 (2007) 928-934
50. Golf S., Lovstad R., and Hansson V. Beta-adrenoceptor density and relative number of beta-adrenoceptor subtypes in biopsies from human right atrial, left ventricular, and right ventricular myocard. Cardiocasc. Res. 19 (1985) 636-641
51. 2+ channels and β-receptors during short- and long-term hyper- and hypothyroidism. Eur. J. Endocrinol. 130 (1994) 171-179
52. Gross G., and Lues I. Thyroid-dependent alterations of myocardial adrenoceptors and adrenoceptor-mediated responens in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 329 (1985) 427-439
53. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Qiniou G., Garrigue S., Le Mouroux A., Le Metayer P., and Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339 (1998) 659-666
54. Hak A.E., Pols H.A., Visser T.J., Drexhage H.A., Hofman A., and Witteman J.C. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in erderly women: the Rotterdam Study. Ann. Intern. Med. 132 (2000) 270-278
55. Hamilton M.A., Stevenson L.W., Fonarow G.C., Steimle A., Goldhaber J.I., Child J.S., Chopra I.J., Moriguchi J.D., and Hage A. Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am. J. Cardiol. 81 (1998) 443-447
56. Hamasaki Y., Shinohara O., Ishida H., Hayashi Y., and Nakazawa H. Decreased protein kinase C-epsilon expression in hypetrophied cardiac ventricles induced by triiodothyronine treatmnet in the rat. Life Sci. 67 (2000) 1859-1868
57. Hammond H.K., White F.C., Buxton I.L.O., Saltzstein P., Brunton L.L., and Longhurst J.C. Increased myocardial beta-receptors and adrenergic responses in hyperthyroid pigs. Am. Physiol. Soc. 252 (1987) H283-H291
58. Han J., Leem C., So I., Kim E., Hong S., Ho W., Sung H., and Earm Y.E. Effects of thyroid hormone on the calcium current and isoprenaline-induced background current in rabbit ventricular myocytes. J. Mol. Cell. Cardiol. 26 (1994) 925-935
59. Harris D.R., Green W.L., and Craelius W. Acute thyroid hormone promotes slow inactivation of sodium current in neonatal cardiac myocytes. Biochim. Biophys. Acta 1045 (1991) 175-181
60. Hennersdorf M.G., and Strauer B.E. Cardiac arrhythmias in hyperthyroidism. Dtsch. Med. Wochenschr. 125 (2000) 637-641
61. Hoit B.D., Khoury S.F., Shao Y., Gabel M., Liggett S.B., and Walsh R.A. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. Circulation 95 (1997) 592-598
62. Hoffman B.F., and Rosen M.R. Cellular mechanisms for cardiac arrhythmias. Circ. Resc. 49 (1981) 1-15
63. Holland F.W., Brown O.S., Weintraub B.D., and Clark R.E. Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". Ann. Thorac. Surg. 52 (1991) 46-50
64. Honjo H., Boyett M.R., Niwa R., Inada S., Yamamoto M., Mitsui K., Horiuchi T., Shibata N., Kamiya K., and Kodama I. Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine. Circulation 107 (2003) 1937-1943
65. Hu Y., Jones S.V., and Dillmann W.H. Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria. Am. J. Physiol. Heart Circ. Physiol. 289 (2006) H1448-H1455
66. 2+ channels. Am. J. Physiol. 279 (2000) H2658-H2664
67. Jaeger J.M., Houser S.R., Freeman A.R., and Spann J.F. Effect of thyroid hormone on canine cardiac Purkinje fiber transmembrane potential. Am. J. Physiol. 240 (1981) H934-H940
68. Jao Y.T., Chen Y., Lee W.H., and Tai F.T. Thyroid storm and ventricular tachycardia. South Med. J. 97 (2004) 604-607
69. Katircibasi M.T., Deniz F., Pamukcu B., Binici S., and Atar I. Effects of short-term propylthiouracil treatment on P wave duration and P wave dispersion in patients with overt hypertyroidism. Exp.Clin. Endocrinol. Diabetes. 115 (2007) 376-379
70. Khoury S.F., Hoit B.D., Dave V., Pawlosky-Dahm C.M., Shao Y., Gabel M., Periasamy M., and Walsh R.A. Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca-cycling proteins in the baboon. Circ. Res. 79 (1996) 727-735
71. Kihara Y., and Mogan J.P. Intracellular calcium and ventricular fibrillation. Circ. Res. 68 (1991) 1378-1389
72. Kim D., and Smith T.W. Effects of thyroid hormone on calcium handling in cultured chick ventricular cells. J. Physiol. 364 (1985) 131-149
73. 2+ transport and myocardial relaxation. Circ. Res. 75 (1994) 245-251
74. Klein I., and Ojamaa K. Thyroid hormone and the cardiovascular system. N. Engl. Med. 344 (2001) 503-509
75. 2+ for electrical cell-to-cell uncoupling and conduction block in myocardial tissues. Basic Res. Cardiol. 87 (1992) 131-143
76. Klein I., and Ojamaa K. Thyroid (neuro)myopathy. Lancet 356 (2000) 614-615
77. Klemperer J.D. Thyroid hormone and cardiac surgery. Thyroid 12 (2002) 517-521
78. Klemperer J.D., Klein I.L., Ojamaa K., Helm R.E., Gomez M., Isom O.W., and Krieger K.H. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann. Thorac. Surg. 61 (1996) 1323-1329
79. Knezl V., Soukup T., Okruhlicová L., Slezák J., and Tribulová N. Thyroid hormones modulate occurrence and termination of ventricular fibrillation by both long-term and acute actions. Physiol. Res. 57 (2008) S91-S96
80. Kokkonen L., Majahalme S., Koobi T., Virtanen V., Salmi J., Huhtala H., Tarkka M., and Mustonen J. Atrial fibrillation in elderly patients after cardiac surgery: postoperative hemodynamics and low postoperative serum triiodothyronine. J. Cardiothorac. Vasc. Anesth. 19 (2005) 182-187
81. Kollai B., and Kollai M. Reduced cardiac vagal excitability in hyperthyroidism. Brain Res. Bull. 20 (1988) 785-790
82. Komiya N., Isomoto S., Nakao K., Hayano M., and Yano K. Electrophysiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism. J. Clin. Endocrinol. Metab. 56 (2002) 39-44
83. Kostin S., Klein G., Szalay Z., Hein S., Bauer E.P., and Schapper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc. Res. 54 (2002) 361-379
84. 2+ - overloaded guinea pig ventricular muscules. Am. J. Physiol., Cell Physiol. 294 (2008) 1419-1429
85. Ladenson P.W. Thyrotoxicosis and the heart: something old and something new. J. Clin. Endocrinol. Metab. 77 (1993) 332-333
86. Lakatta E.G., and Guarnieri T. Spontaneous myocardial calcium oscillations: are they linked to ventricular fibrillation?. J. Cardiovasc. Electrophysiol. 4 (1993) 473-489
87. Lee J.K., and Lewis J.A. Myxedema with complete A-V-block and Adams-Stokes disease abolished with thyroid medication. Br. Heart J. 24 (1962) 253-256
88. Le Bouter S., Demolombe S., Chambellan A., Bellocq C., Aimond F., Toumaniantz G., Lande G., Siavoshian S., Baro I., Pond A.L., Nerbonne J.M., Leger J.J., Escande D., and Charpentier F. Microarray analysis reveals complex remodeling of cardiac ion channel expression with altered thyroid status: relation to cellular and integrated electrophysiology. Circ. Res. 92 (2003) 34-42
89. Lin H., Mitasikova M., Dlugosova K., Okruhlicova L., Imanaga I., Ogawa K., Weismann P., and Tribulova N. Thyroid hormones suppress ε-PKC signalling, down-regulate connexin-43 and increase lethal arrhythmia susceptibility in non-diabetic and diabetic rat hearts. J. Physiol. Pharmacol. 59 (2008) 271-285
90. Liu P., Fei L., Wu W., Li J., Wang J., and Zhang X. Effects of hypothyroidism on the vulnerability to ventricular fibrillation in dogs: a comparative study with amiodarone. Cardiovasc. Drugs Ther. 10 (1996) 369-378
91. Lomax R.B., Cobbold P.H., Allshire A.P., Cuthbertson K.S., and Robertson W.R. Tri-iodothyronine increases intracellular calcium levels in single rat myocytes. J. Mol. Endocrinol. (1991) 77-79
92. Ma M.L., Watanabe K., Watanabe H., Hosaka Y., Komura S., and Aizawa Y. Different gene expression of potassium channels by thyroid hormone and an antithyroid drug between the atrium and ventricle of rats. Jpn. Heart J. 44 (2003) 101-110
93. MacKerrow S.D., Osborn L.A., Levy H., Eaton R.P., and Economou P. Myxedema-associated cardiogenic shock treated with intravenous triiodothyronine. Annals Intern. Med. 117 (1992) 1014-1015
94. 2+ current in guinea pig ventricular myocytes. Pflugers Arch. 421 (1992) 425-430
95. Makusheva M.V., and Kileinikov D.V. Arrhythmia and vegetative imbalance in hypothyrosis patients. Ter. Arkh. 80 (2008) 34-36
96. Manoach M., Tribulová N., Vogelezang D., Thomas S., and Podzuweit T. Transient ventricular fibrillation and myosin heavy chain isoform profile. J. Cell. Mol. Med. 11 (2007) 171-174
97. Meo S.D., de Martino Rosaroll P., Piro M.C., and De Leo T. Electrophysiological properties of the hyperthyroid rat heart. Arch. Int. Physiol. Biochim. Biophys. 102 (1994) 153-159
98. Merrilat J.C., Lakatta E.G., Hano O., and Guarnieri T. Role of calcium and the calcium channel in the initiation and maintenance of ventricular fibrillation. Circ. Res. 67 (1990) 115-1123
99. Mitasikova M., Lin H., Soukup T., Imanaga I., and Tribulova N. Diabetes and thyroid hormones affect connexin-43 and PKC-ε expression in rat heart atria. Physiol. Res. 58 (2009) 211-217
100. Morkin E. Regulation of myosin heavy chain genes in the heart. Circulation 87 (1993) 1451-1459
101. Morkin E., Pennock G.D., Spooner P.H., Bahl J.J., and Goldman S. Clinical and experimental studies on the use of 3, 5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 12 (2002) 527-533
102. 2+-ATPase activity and share structural homologies. Biochemistry 82 (1985) 7974-7978
103. Nadkarni P.J., Sharma M., Zinsmeister B., Warfolsky L., and Burman K.D. Thyrotoxicosis-induced ventricular arrhythmis. Thyroid 18 (2008) 1111-1114
104. Nakamura T.Y., Coetzee W.A., Miera E.V.D., Artman M., and Rudy B. Modulation of Kv4 channels, key components of rat ventricular transient outward K+ current, by PKC. Am. J. Physiol. Heart Circ. Physiol. 273 (1997) H1775-H1786
105. Ninio D.M., Murphy K.J., Howe P.R., and Saint D.A. Dietary fish oil protects against strech-induced vulnerability to atrial fibrillation in a rabbit model. J. Cardiovasc. Electrophysiol. 16 (2005) 1189-1194
106. Nishiyama A., Kambe F., Kamiya K., Seo H., and Toyama J. Effect of thyroid status on expression of voltage-gated potassium channels in rat left ventricle. Cardiovasc. Res. 40 (1998) 343-351
107. Ojamaa K., Sabet A., Kenessey A., and Shenoy R. Regulation of rat cardiac Kv 1.5 gene expression by thyroid hormone is rapid and chamber specific. Endocrinology 140 (1999) 3170-3176
108. Ojamaa K., Kenessey A., and Klein I. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology 141 (2000) 2139-2144
109. Osborn L.A., Skipper B., Arellano I., MacKerow S.D., and Crawford M.H. Results of resting and ambulatory electrocardiograms in patients with hypothyroidism and after return to euthyroid status. Heart Dis. 1 (1999) 8-11
110. Oshiro Y., Shimabukuro M., Takasu N., Asahi T., Komiya I., and Yoshida H. Triiodothyronine concomitantly inhibitis calcium overload and postischemic myocardial stunning in diabetic rats. Life Sci. 69 (2001) 1907-1918
111. Osman F., Gammage M.D., and Franklyn J.A. Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid 12 (2002) 483-487
112. Osman F., Gammage M.D., Sheppard M.C., and Franklyn J.A. Cardiac dysrhythmias and thyroid dysfunction: the hidden menace?. J. Clin. Endocrinol. Metab. 87 (2002) 963-967
113. Pantos C., Mourouzis I., Xinaris Ch., Papadopoulou-Daifoti Z., and Cokkinos D. Thyroid hormones and cardiac methamorphosis. Potential therapeutic implication. Pharmacol. Ther. 118 (2008) 277-294
114. Park Y.J., Yoon J.W., Kim K.I., Lee Y.J., Kim K.W., Choi S.H., Lim S., Choi D.J., Park K.H., Choh J.H., Jang H.C., Kim S.Y., Cho B.Y., and Lim C. Subclinical hypothyroidism might increase the risk of transient atrial fibrillation after coronary artetry bypass grafting. Ann. Thorac. Surg. 87 (2009) 1846-1852
115. Polikar R., Burger A.G., Scherrer U., and Nicod. The thyroid and the heart. Circulation 87 (1993) 1435-1441
116. Polikar R., Goy J.J., Schlaper J., Lemarchand-Beraud T., Biollaz J., Magnenat P., and Nicod P. Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes. Am. J. Cardiol. 58 (1986) 987-991
117. Qu Z., and Weiss J.N. Dynamics and cardiac arrhythmias. J. Cardiovasc. Electrophysiol. 17 (2006) 1042-1049
118. 2+ exchanger are antithetically regulated during mouse cardiac development and in hypo/hyperthyroidism. J. Mol. Cell. Cardiol. 32 (2000) 453-464
119. Renaudon B., Lenfant J., Decressac S., and Bois P. Thyroid hormone increase the conductance density of f-channels in rabbit sino-atrial node cells. Recept. Channels 7 (2000) 1-8
120. Rybin V., and Steinberg S.F. Thyroid hormone represses protein kinase C isoform and activity in rat cardiac myocytes. Circ. Res. 79 (1996) 388-398
121. Sakaguchi Y., Cui G., and Sen L. Acute effects of thyroid hormone on inward rectifier potassium channel currents in guinea pig ventricular myocytes. Endocrinology 137 (1996) 4744-4751
122. Salameh A., and Dhein S. Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer?. Biochim. Biophys. Acta 1719 (2005) 36-58
123. Salter D.R., Dyke C.M., and Wechsler A.S. Triodothyronine (T3) and cardiovascular therapeutics: a review. J. Card. Surg. 7 (1992) 363-374
124. Sarma J.S., Venkataraman K., Nicod P., Polikar R., Smith J., Schoenbaum M.P., and Singh B.N. Circadian rhythmicity of rate-normalized QT interval in hypothyroidism and its significance for development of class III antiarrhythmic agents. Am. J. Cardiol. 66 (1990) 959-963
125. Savelieva I., and Camm J. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation. Nat. Clin. Pract. Cardiovasc. Med. 5 (2008) 30-41
126. Sawin C.T. Subclinical hyperthyroidism and atrial fibrillation. Thyroid 12 (2002) 501-503
127. Sawin C.T., Geller A., Wolf P.A., Belanger A.J., Baker E., Bacharach P., Wilson P.W., Benjamin E.J., and D'Agostino R.B. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N. Engl. J. Med. 331 (1994) 1249-1252
128. Schenck J.B., Rizvi A.A., and Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am. J. Med. Sci. 331 (2006) 154-156
129. Segal J. Calcium is the first messenger for the action of thyroid hormone at the level of the plasma membrane: First evidence for an acute effect of thyroid hormone on calcium uptake in the heart. Endocrinology 126 (1990) 2693-2702
130. Segal J., Masalha S., Schwalb H., Merin G., Borman J.B., and Uretzky G. Acute effect of thyroid hormone in the rat heart: role of calcium. J. Endocrin. 149 (1996) 73-80
131. Severs N.J. Gap junction remodelling and cardiac arhythmogenesis: cause or coincidence?. J. Cell. Mol. Med. 5 (2001) 355-366
132. Shenoy R., Klein I., and Ojamaa K. Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles. Am. J. Physiol. 281 (2001) H1690-H1696
133. Shimizu T., Koide S., Noh J.Y., Sugino K., Ito K., and Nakazawa H. Hyperthyroidism and the management of atrial fibrillation. Thyroid 12 (2002) 489-493
134. Shimoni Y., Banno H., and Clark R.B. Hyperthyroidism selectively modified a transient potassium current in rabbit ventricular and atrial myocytes. J. Physiol. 457 (1992) 369-389
135. Shimoni Y., and Banno H. Alfa-adrenergic modulation of transient outward current in hyperthyroid rabbit myocytes. Am. J. Physiol. 264 (1993) H74-H77
136. Shimoni Y., Severson D., and Giles W. Thyroid status and diabetes modulate regional differences in potassium currents in rat ventricle. J. Physiol. 488 (1995) 673-688
137. Shimoni Y., Fiset C., Clark R.B., Dixon K.E., McKinnon D., and Giles W. Thyroid hormone regulates postnatal expression of transient K+ channel isoforms in rat ventricle. J. Physiol. 500 (1997) 65-73
138. Shimoyama N., Maeda T., Inoue T., Niwa H., and Saikawa T. Serum thyroid hormone levels correlate with cardiac function and ventricular tachyarrhythmia in patients with chronic heart failure. J. Cardiol. 23 (1993) 205-213
139. Stagg R.B., and Flechter W.H. The hormone-induced regulation of contact-dependent cell-cell communication by phosphorylation. Endocr. Rev. 11 (1990) 302-305
140. Stock A., and Sies H. Thyroid hormone receptors bind to an element in the connexin43 promoter. Biol. Chem. 381 (2000) 973-979
141. Stock A., Sies H., and Stahl W. Enhancement of gap junctional communication and connexin43 expression by thyroid hormones. Biochem. Pharmacol. 55 (1998) 475-479
142. Sun Z.Q., Ojamaa K., Coetzee W.A., Artman M., and Klein I. Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes. Am. J. Physiol. Endocrinol. Metab. 278 (2000) 302-307
143. Sun Z.Q., Ojamaa K., Nakamura T.Y., Artman M., Klein I., and Coetzee W.A. Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J. Mol. Cell. Cardiol. 33 (2001) 811-824
144. Sunagawa M., Yamakawa M., Shimabukuro M., Higa N., Takasu N., and Kosugi T. Electrophysiologic characteristics of atrial myocytes in levo-thyroxine-treated rats. Thyroid 15 (2005) 3-11
145. Tielens E.T., Forder J.R., Chatham J.C., Marelli S.P., and Ladenson P.W. Acute l-triiodothyronine administration potentiates inotropic responses to beta-adrenergic stimulation in the isolated perfused rat heart. Cardiovasc. Res. 32 (1996) 306-310
146. Toft A.D., and Boon N.A. Thyroid disease and the heart. Heart 84 (2000) 455-460
147. Tribulova N., Varon D., Polak-Charcon S., Buscemi P., Slezak J., and Manoach M. Aged heart as a model for prolonged atrial fibrillo- flutter. Exper. Clin. Cardiol. 4 (1999) 64-72
148. +-induced ventricular fibrillation. Physiol. Res. 50 (2001) 247-259
149. Tribulova N., Okruhlicova L., Varon D., Manoach M., Pechanova O., Bernatova I., Weismann P., Barancik M., Styk J., and Slezak J. Structural substrates involved in the development of severe arrhythmias in hypertensive rat and aged guinea pig hearts. In: Dhalla N.S., and Singal P. (Eds). Cardiac Remodeling and Failure (2002), Kluwer Academic Publishers, Boston, USA 377-398
150. Tribulova N., Okruhlicova L., Imanaga I., Hirosava N., Ogawa K., and Weismann P. Factors involved in the susceptibility of spontaneously hypertensive rast to low K+- induced arrhythmias. Gen. Physiol. Biophys. 22 (2003) 369-382
151. Tribulova N., Hailin H., Imanaga I., Knezl V., Seki S., and Manoach M. Factors involved in the antiarrhythmic and proarrhythmic effects of thyroid hormones. J. Mol. Cell. Cardiol. 37 (2004) 310-311
152. Tribulova N., Knezl V., Okruhlicova L., Drimal J., Lamosova D., Slezak J., and Styk J. L-thyroxine increases susceptibility of young rats to low K+ -induced venticular fibrillation while facilitates sinus rhythm restoration in old one. Exper. Physiol. 89 (2004) 629-636
153. Tribulova N., Shneyvays V., Mamedova K.L., Moshel S., Zinman T., Shainberg A., Manoach M., Weismann P., and Kostin S. Enhanced connexin-43 and alfa-sarcomeric actin expression in cultured heart myocytes exposed to triiodo-l-thyronine. J. Mol. Histol. 35 (2004) 463-470
154. Tribulová N., Dupont E., Soukup T., Okruhlicová L., and Severs N.J. Sex differences in connexin-43 expression in left ventricles of aging rats. Physiol. Res. 54 (2005) 705-708
155. Tribulova N., Knezl V., Okruhlicova L., and Slezak J. Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias. Physiol. Res. Suppl. 2 (2008) S1-S13
156. Tribulova N., Seki S., Radosinska J., Kaplan P., Babusikova E., Knezl V., and Mochizuki S. Myocardial Ca2+ handling and cell-to-cell coupling, key factors in prevention of sudden cardiac death. Canadian J. Physiol. Pharmacol. 87 (2009) 1120-1129
157. Unal O., Erturk E., Ozkan H., Kiyici S., Guclu M., Ersoy C., Yener F., and Imamoglu S. Effects of levothyroxine treatment on QT dispersion in patients with subclinical hypothyroidism. Endocr. Pract. 13 (2007) 711-715
158. Van Heerden B.B., Klopper J.F., Weich H.F., and Van Herden P.D. The effect of heparin induced increase of free plasma thyroxine on cardiac rhythm after myocardial infarction. S. Afr. Med. J. 21 68 (1985) 952-955
159. Venkatesh N., Lynch J.J., Uprichard A.C., Kitzen J.M., Singh B.N., and Lucchesin B.R. Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death. J. Cardiovasc. Pharmacol. 18 (1991) 703-710
160. Vergara P., Picardi G., Nigro G., Scafuro F., de Chiara A., Calabro R., and Vergara G. Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation. Anadolu Kardiyol Derg. 1 (2007) 104-106
161. Von Olshausen K., Bischoff S., Kahaly G., Mohr-Kahaly S., Erbel R., Beyer J., and Meyer J. Cardiac arrhythmias and heart rate in hyperthyroidism. Am. J. Cardiol. 63 (1989) 930-933
162. Waktare J.E., Hnatkova K., Sopher S.M., Murgatroyd F.D., Guo X., Camm A.J., and Malik M. The role of atrial ectopics in initaiting paroxysmal atrial fibrillation. Eur. Heart. J. 22 (2001) 333-339
163. Walsh J.P., Bremner A.P., and Bulsara M.K. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch. Intern. Med. 165 (2005) 2467-2472
164. Wang Y.G., Dedkova E.N., Fiening J.P., Ojamaa K., Blatter L.A., and Lipsius S.L. Acute exposure to thyroid hormone increases Na+ current and intracellular Ca2+ in cat atrial myocytes. J. Physiol. (2003) 546-549
165. Watanabe H., Ma M., Washizuka T., Komura S., Yoshida T., Hosaka Y., Hatada K., Chinushi M., Yamamoto T., Watanabe K., and Aizawa Y. Thyroid hormone regulates mRNA aexpression and currents of ion channels in rat atrium. Biochem. Biophys. Res. Commun. 3 (2003) 439-444
166. Watanabe H., Washizuka T., Komura S., Yoshida T., Hosaka Y., Hatada K., Aizawa Y., Chinushi M., Yamamoto T., Ma M., and Watanabe K. Genomic and nongenomic regulation of L-type calcium channels in rat ventricle by thyroid hormone. Endocr. Res. 31 (2005) 59-70
167. Wheatley A.M., Butkow N., Marcus R.H., Lippe I.T., and Rosendorff C. Enhanced myocardial contractility but not tachycardia persists in isolated working hyperthyroid rat hearts. Basic Res. Cardiol. 83 (1988) 634-646
168. + channel gene expression in rat ventricle. J. Physiol. 504 (1997) 271-286
169. Wickenden A.D., Kaprielian R., You X.M., and Backx P.H. The thyroid hormone analog DITPA restores I(to) in rats after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H1105-H1116
170. Woeber K.A. Thyrotoxicosis and the heart. N. Engl. J. Med. 327 (1992) 94-98
171. Wustman K., Kucera J.P., Zanchi A., Burow A., Stuber T., Chappuis B., Diem P., and Delacretaz E. Activation of electrical triggers of atrial fibrillation in hyperthyroidism. J. Clin. Endocrinol. Metab. 93 (2008) 2104-2108
172. Xia H.-J., Dai D.-Z., and Dai Y. Up-regulated inflammatory factors endothelin, NFkB, TNFa and iNOS involved in exaggerated cardiac arrhytmias in l-thyroxine-induced cardiomyopathy are suppressed by durasentan in rats. Life Sci. 79 (2006) 1812-1819
173. Xia H.J., Dai D.Z., and Dai Y. Up-regulated inflammatory factors endothelin, NFkappaB, TNFalpha and iNOS involved in exaggerated cardiac arrhythmias in thyroxine-induced cardiomyopathy are suppressed by darusentan in rats. Life Sci. 79 (2006) 1812-1819
174. Yamakawa M., Sunagawa M., Shimabukuro M., Higa N., Takasu N., and Kosugi T. Effects of sodium channel blocker pilsicainide hydrochloride, on net inward current of atrial myocytes in thyroid hormone toxicosis rats. Thyroid 15 (2005) 653-659
175. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 81 (2001) 1097-10142
176. Zhang L., Parratt J.R., Beastall G.H., Pyne N.J., and Furman B.L. Streptozotocin diabetes protects against arrhythmias in rat isolated hearts: role of hypothyroidsm. Eur. J. Pharmacol. 435 (2002) 269-276
177. Zinman T., Shneyvays V., Tribulová N., Manoach M., and Shainberg A. Acute, nongemonic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes. J. Cell. Physiol. 207 (2006) 220-231